The ETERNAL project's penultimate General Assembly Meeting, struck a positive and industrious note as the project partners gear up their activities and focus upon scale-up and adoption of Green Pharma innovation across the project’s six industrial case studies and supporting research into enhanced Environmental Risk Assessment and Digitalisation of Pharma processes and workflows.

ETERNAL's latest white paper publication provides an evaluation of how to embed early-stage thinking about safety and sustainability in process (re)design as applied to an industrial case study involving five different options for re-engineering acetone from water solvent recovery in part of a commercial API manufacturing process.